Structural Heart Market was valued at US$ 6,406.3 Mn in 2017 and is estimated to reach US$ 13,850.2Mn by 2025

 According to a new market research study titled ‘Structural Heart Market to 2025 – Global Analysis and Forecasts by Product, Procedure and End User. The global structural heart market is estimated to account for US$ 13,850.2Mn by 2025 as compared to US$ 6,406.3 Mn in 2017, growing at a CAGR of 10.5% during the forecast period from 2018 to 2025. The report highlights the trends prevalent in the global structural heart market and the factors driving the market along with those fact as restraint to its growth.

The growth of the market is expected rise due to the trend of technological advancement. The technological advancements for the structural heart is growing at a speedy rate with plentiful amount of the interventions in cardiology and increase in the adoption of new cardiology surgeries such as coronary intervention and structural intervention as lower down the rate of the open heart surgeries. The transcatherter procedures have provides various advantages against the surgical intervention in the recent time and has led to improvements of patient is shorter period of time.

In addition, the patients’ satisfaction has increased due to the use of less minimally invasive procedures, these procedures have reduced the surgical risks and cardio-pulmonary risks. Transcatheter aortic valve replacement (TAVR) has gathered more attention due to offering a reasonable option of treatment of degenerative aortic stenosis over last ten years. For instance, Edwards Lifesciences’s Edwards Sapien valve was under the studies in the PARTNER trial. This valve was made up of a bovine pericardial tissue valve and was sutured on a cobalt chromium stent scaffold. The stent allowed the valve to be folded to a lower profile to maintain the structural and radial support once it is expanded.

Get PDF Sample Copy @ https://www.theinsightpartners.com/sample/TIPHE100001164/

Key industry players operating in the field of structural heart across the globe include Abbott, Medtronic, Boston Scientific Corporation, CryoLife Ins, Edwards Lifesciences Corporation, LivaNova Plc, Lepu Medical, Braile Biomedica, Labcor Laboratorios Ltda, Aran biomedical Teornta among others.

The innovative structural heart services is expected to drive the market of structural heart in the forecasted period. The innovations are not only limited to the healthcare facilities however they are stretched out to the programs that are being designed for the patients to get benefit out of the treatment facilities. Food and Drug Administration (FDA) has approved various therapies that are limited to the selected groups of the patients.

There some personal healthcare provider who analyze the heart condition and available treatment of choices. For instance, Premier Health is among those providers who provides innovative structural heart services which include alcohol septal ablation which treats hypertrophic cardiomyopathy with the use of catheter-based technology, balloon valvuloplasty which uses a transcatheter approach for widening up a stiff and narrow heart valves, atrial septal defect transcatheter repair which closes an opening between the heart’s left and right atrium without surgery and such more services are being provided by the service providers.

The innovative structural heart programs’ innovative technology and techniques are specifically designed to provide quality care for best results for patients and provides less complications and shorter recoveries times with long lasting advantages. Therefore, offering the innovative services for the structural heart are likely to boost the market in the forecasted years. Such services are likely to attract more patients suffering from the structural heart diseases and eventually the benefits of the services are likely to robust the growth of the market in the forecasted period.

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us:

If you have any queries about this report or if you would like further information, please

Contact Person: Sameer Joshi

E-mail: sales@theinsightpartners.com

Phone: +1-646-491-9876

Comments

Post a Comment

Popular posts from this blog

Medical Imaging Market Size is expected to reach US$ 33,002.52 Mn by 2028

The Global   Medical Imaging Market   was valued at US$ 23,901.88 million in 2020 and is anticipated to be worth US$ 33,002.52 million by 2028, recording a stellar annual growth rate of 4.3% from 2021 to 2028. Introduction of technologically advanced systems and increasing demand for early diagnosis are the potential aspects assisting the market expansion. Medical imaging is an integral part of clinical procedures. Radiologists use ultrasound, MRIs, and CT scans for proper diagnosis and treatment. Over the past few decades, the capabilities of medical imaging have increased radially. Besides, artificial intelligence (AI) has helped improve the critical aspects of healthcare industry, with medical imaging being a prime area of benefit. In February 2018, Aidoc, a deep learning startup, revealed world’s first comprehensive full-body technology that uses AI to analyze CT scans. In September 2018, Nvidia unveiled Nvidia Clara platform that integrates AI in future medical ...
Read more

Epigenetics Market Size, Share, Trends, Brand Strategy, Consumption, Future Opportunities, Types Forecast to 2025

The global   Epigenetics Market   is segmented based on deployment, component, solution, application, and geography. The segmentation in this research study has been finalized post in-depth secondary research and extensive primary research. In addition, the market is also segmented on the basis of products offered by the leading participants in the industry in order to understand widely used market specific terminologies. Thus, we have incorporated the segments of the research and have finalized the market segmentation. The research report focuses on the current market trends, opportunities, future potential of the market, and competition in the Epigenetics in North America, Europe, Asia-Pacific, Middle East & Africa, and South America. The study also provides market insights and analysis of the Epigenetics, highlighting the technological market trends, adoption rate, industry dynamics, and competitive analysis of major players in the industry. The declining costs associat...
Read more

Intraoperative Neuromonitoring Market is expected to reach US$ 4,199.95 Mn by 2027

Intraoperative Neuromonitoring Market study by “The Insight Partners” provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. Based on product, the global  Intraoperative Neuromonitoring Market  is segmented into system, accessories, and services.  The system segment held the largest share of the market in 2019; however, the services segment is anticipated to register the highest CAGR in the market during the forecast period. Growing demand of intraoperative neuro monitors is the key factor driving the growth of the segment. Additionally, several key players are focusing in offering intraoperative neuromonitoring services such as Specialty Care, Sentient Medical Systems, Medtronic, and Natus Medical and Nuvasive. These factors are likely to enhance the growth of the market during the forecast ...
Read more